Knockdown or silencing of glycolytic genes such as HK2, PKFP, ALDOA, PGAM1, ENO1, ENO2, or PDK1 inhibits GBM tumor growth and prolongs survival in a mouse xenograft model [11]. Here, ENO1 is linked to glioblastoma.